Here are eight highlights:
1. The global orthopedic biomaterial market is expected to hit $38.1 billion by 2020.
2. In 2015, the market totaled 22.07 billion.
3. Surgeons are using orthopedic biomaterials to treat musculoskeletal and joint-related disorders.
4. Of the orthopedic biomaterials, metal is most commonly used, especially in arthroplasty and fracture fixation devices.
5. The ceramics, polymers and orthobiologics segments will likely experience double digit growth between 2015 and 2020.
6. More hip and knee replacements and a larger geriatric population will spur market growth.
7. Many countries’ governments are also funding the development of advanced biomaterials.
8. The failure of joint implants and the costliness of biomaterial production will pose as obstacles to market growth.
More articles on devices:
Spinal Simplicity updates Minuteman G3 fusion devices with HA coating: 5 key notes
Zimmer Biomet, DePuy Synthes are key vendors shaping the European large joint orthopedic devices market — 4 things to know
Orange County Technology Alliance recognizes Vertos Medical for LSS procedure: 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
